GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 82 filers reported holding GALENA BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $34,000 | -46.0% | 21,476 | -29.7% | 0.00% | 0.0% |
Q3 2015 | $63,000 | -6.0% | 30,566 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $67,000 | +2133.3% | 30,566 | +56503.7% | 0.00% | – |
Q1 2015 | $3,000 | -99.5% | 54 | -100.0% | 0.00% | -100.0% |
Q4 2014 | $596,000 | +6.4% | 139,805 | +28.1% | 0.01% | 0.0% |
Q3 2014 | $560,000 | +4.1% | 109,105 | +33.1% | 0.01% | +9.1% |
Q2 2014 | $538,000 | – | 81,955 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
Matisse Capital | 17,000 | $25,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |